Kadmon to Present at the Jefferies 2012 Global Healthcare Conference
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 05/30/12 -- today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer of Kadmon, will present at the Jefferies 2012 Global Healthcare Conference on Wednesday, June 6th at 10:00 a.m. Eastern Time at the Grand Hyatt in New York City. Dr. Waksal will provide an overview of the Company and its commercial and clinical programs.
A live audio webcast of the presentation will be accessible through Kadmon's website at . The webcast will be archived for 90 days.
Kadmon Corporation, LLC is a global company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of hepatitis C. Kadmon is pioneering medicines in oncology, infectious diseases, immunology and neurodegenerative diseases by using emerging concepts in molecular biology and genomics to develop therapies that target the metabolomic and signaling pathways associated with disease. For more information, visit .
For Kadmon Corporation, LLC:
Argot Partners
David Pitts
212-600-1902
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.05.2012 - 07:45 Uhr
Sprache: Deutsch
News-ID 1119160
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 156 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Kadmon to Present at the Jefferies 2012 Global Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Kadmon Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
